Lanean...
Prospective clinical trial of rifaximin therapy for patients with primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease in which emerging data suggest that oral antibiotics may offer therapeutic effects. We enrolled patients with PSC in a 12-week open-label pilot study to investigate the efficacy and safety of oral rifaximin 550 mg twi...
Gorde:
| Argitaratua izan da: | Am J Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261045/ https://ncbi.nlm.nih.gov/pubmed/24914504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MJT.0000000000000102 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|